Ipamorelin vs Tesamorelin
Ipamorelin and tesamorelin act at different levels of the GH axis. A US research comparison of receptor targets, model systems and published data.
Side-by-side research comparisons of peptides with overlapping mechanisms or targets.
Ipamorelin and tesamorelin act at different levels of the GH axis. A US research comparison of receptor targets, model systems and published data.
CJC-1295 with DAC and CJC-1295 no-DAC are different research compounds, not two strengths of one. What the albumin conjugate changes, and why.
How semaglutide and retatrutide differ at the receptor, what the 2026 rodent data actually show, and how to source either for US laboratory work.
Ipamorelin, CJC-1295, tesamorelin and GHRP-6 act on two different receptors, not one. A preclinical comparison with US sourcing and COA notes.
BPC-157 vs TB-500 compared on mechanism, model systems and the 2026 head-to-head rat Achilles study — including what the combination arm actually showed.